Koyfin Home > Directory > Health Care > Pieris Pharma > Capital Expenditures

Pieris Pharma Capital Expenditures Chart (PIRS)

Pieris Pharma annual/quarterly Capital Expenditures from 2013 to 2020.
  • Pieris Pharma Capital Expenditures for the quarter ending September 09, 2020 was $1m a 240.00% increase of 2m year over year
  • Pieris Pharma Capital Expenditures for the last 12 months ending September 09, 2020 was $-3m a 25.93% decrease of -1m year over year
  • Pieris Pharma Annual Capital Expenditures for 2019 was $-2m a 31.03% decrease of -1m from 2018
  • Pieris Pharma Annual Capital Expenditures for 2018 was $-2m a -14.84% increase of 0m from 2017
  • Pieris Pharma Annual Capital Expenditures for 2017 was $-2m a 71.28% decrease of -1m from 2016
Other Cash Flow Metrics:
  • Pieris Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $-14m a 67.31% decrease of -10m year over year
  • Pieris Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-21m a 96.92% decrease of -20m year over year
  • Pieris Pharma Total Revenue for the quarter ending September 09, 2018 was $8m a -117.52% decrease of -10m year over year
View Chart On Koyfin

Quarterly PIRS Capital Expenditures Data

09/2020$1m
06/2020$-1m
03/2020$-2m
12/2019$-1m
09/2019$0m
06/2019$-1m
03/2019$0m
12/2018$-1m
09/2018$0m
06/2018$0m

Annual PIRS Capital Expenditures Data

2019$-2m
2018$-2m
2017$-2m
2016$-1m
2015$-1m
2014$0m
2013$0m
2012$0m